Additional information
| Strength | 10mg, 5mg |
|---|
Cagrisema (Cagrilintide + Semaglutide)
Price range: $80.00 through $135.00
Product Classification
Classified as a metabolic research combination
Description
Cagrisema combines amylin analogue cagrilintide with GLP-1 receptor agonist semaglutide.
Research investigates complementary signaling pathways affecting appetite, satiety, glucose homeostasis, and adiposity
Specifications
- Molecular Type: Peptide/peptidomimetic combination
- Mechanisms: Amylin + GLP-1 agonism
Research Notes
- Metabolic Synergy: preclinical literature reports enhanced weight reduction vs monotherapy.
- - Appetite & Satiety: dual satiety pathway engagement.
- Glycemic Control: GLP-1 component modulates insulin secretion and glucose tolerance
- Adiposity: interest in fat mass reductions and improved metabolic marker
Regulatory Statement
For research use only. Not for human or animal consumption.
Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent disease
Related products
-
– CJC-1295 with DAC (Drug Affinity Complex)
Price range: $75.00 through $130.00 Select options This product has multiple variants. The options may be chosen on the product page -
CJC-1295 (No DAC) + Ipamorelin
$70.00 Select options This product has multiple variants. The options may be chosen on the product page -
ACTH 1-39 (Adrenocorticotropic Hormone, 39 amino acids)
$60.00 Select options This product has multiple variants. The options may be chosen on the product page -
Dihexa (Nootropic Peptidomimetic)
Price range: $30.00 through $60.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.